Kari Hemminki
11 – 20 of 520
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
(
- Contribution to journal › Letter
-
Mark
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
(
- Contribution to journal › Article
-
Mark
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia : a CRuCIAL study
(
- Contribution to journal › Letter
- 2021
-
Mark
Types of second primary cancer influence overall survival in cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Characterization of rare germline variants in familial multiple myeloma
(
- Contribution to journal › Letter
-
Mark
Familial Risks between Pernicious Anemia and Other Autoimmune Diseases in the Population of Sweden
(
- Contribution to journal › Article
-
Mark
Family history of head and neck cancers
(
- Contribution to journal › Article
-
Mark
Second primary cancers after liver, gallbladder and bile duct cancers, and these cancers as second primary cancers
(
- Contribution to journal › Article
-
Mark
Familial risks and proportions describing population landscape of familial cancer
(
- Contribution to journal › Article